FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used for prediction and early diagnosis of diabetic macular edema (DME). Venous blood is sampled. Bradykinin (Bk) and angiotensin-converting enzyme (ACE) - Bk/ACE are measured in serum. If Bk to ACE ratio is more than 0.107, occurrence or diagnosis of DME is predicted.
EFFECT: use of the invention enables accurate determination of DME risk factors for developing a preventive adequate therapeutic approach at the early stages of DME development and determining readings for dynamic observation.
1 cl, 3 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF INTRAOPERATIVE HAEMORRHAGIC COMPLICATIONS IN THE SEVERE FORM OF PROLIFERATIVE DIABETIC RETINOPATHY | 2018 |
|
RU2696880C1 |
| METHOD FOR DETERMINING THE RISK FACTOR FOR THE PRESENCE OF DIABETIC RETINOPATHY IN PATIENTS WITH DIABETES MELLITUS | 2022 |
|
RU2804729C1 |
| METHOD FOR PREDICTING INTRAOPERATIVE HEMORRHAGIC COMPLICATIONS IN HEAVY FORM OF DIABETIC RETHYNOPATHY | 2016 |
|
RU2626681C1 |
| METHOD FOR FORECASTING DEGREE OF RISK OF DIABETES MACULAR EDEMA DEVELOPMENT IN PATIENTS WITH TYPE II SUGAR DIABETES | 2007 |
|
RU2334469C1 |
| METHOD FOR TREATING THE CASES OF DIABETIC RETINOPATHY | 2002 |
|
RU2212869C1 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF DIABETIC RETINOPATHY IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2809639C1 |
| METHOD FOR PREVENTION OF DIABETIC RETINOPATHY PROGRESSION IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2814772C1 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF DIABETIC MACULAR EDEMA IN PATIENTS AT TYPE II DIABETES | 2006 |
|
RU2314072C1 |
| METHOD FOR EARLY DIAGNOSTICS AND PREDICTION OF DIABETIC AND HYPERTENSIVE RETINOPATHY PROGRESSING IN CASE OF COMBINED COURSE OF TYPE 2 DIABETES MELLITUS AND HYPERTENSIVE DISEASE | 2015 |
|
RU2610535C1 |
| METHOD OF COMBINED TREATMENT OF DIABETIC DIFFUSE MACULAR EDEMA | 2011 |
|
RU2486878C1 |
